American Century Companies Inc Amarin Corp Plcuk Transaction History

American Century Companies Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $1.25 Million - $1.64 Million	-308,277 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.64 - $7.76 $12,972 - $27,656	3,564 Added 1.17%	308,277 $1.3 Million
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $307,865 - $532,001	64,407 Added 26.8%	304,713 $2.11 Million
Q1 2020 May 14, 2020	SELL	$4.0 - $21.53 $57,048 - $307,060	-14,262 Reduced 5.6%	240,306 $961,000
Q4 2019 Feb 12, 2020	SELL	$13.94 - $24.12 $182,516 - $315,803	-13,093 Reduced 4.89%	254,568 $5.46 Million
Q3 2019 Nov 13, 2019	BUY	$13.89 - $23.16 $1.96 Million - $3.27 Million	141,189 Added 111.64%	267,661 $4.06 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $500,416 - $630,826	30,757 Added 32.13%	126,472 $2.45 Million
Q1 2019 May 14, 2019	BUY	$12.61 - $22.33 $1.21 Million - $2.14 Million	95,715 New	95,715 $0

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.